Tirzepatide

Tirzepatide

• Form: Lyophilized Powder

• Purity: 99% (HPLC Verified — Third Party Tested)

• Common Research Areas: Dual-incretin receptor pharmacology, GIP/GLP-1 signaling pathway studies, glucose homeostasis research, metabolic pathway modulation

• Storage: Store lyophilized powder in the freezer for long-term storage. Once reconstituted, store in the refrigerator.  Keep away from light and moisture.

• Certificate of Analysis: Available on our Lab Reports page

• For Research Use Only — Not for Human or Animal Consumption

Tirzepatide is a synthetic dual glucose-dependent insulin tropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that has generated significant interest within the peptide research community for its unique dual-incretin mechanism of action. Unlike earlier-generation compounds that target only the GLP-1 receptor, Tirzepatide has been engineered to activate both the GIP and GLP-1 receptors simultaneously, offering researchers a distinctive model for studying the potential synergistic effects of combined incretin pathway activation.

The dual-agonist profile of Tirzepatide has made it a compound of considerable interest in metabolic research, receptor pharmacology studies, and investigations into glucose homeostasis mechanisms. Researchers studying incretin biology have used Tirzepatide as a tool compound to better understand how simultaneous GIP and GLP-1 receptor engagement may influence downstream signaling cascades differently than single-receptor agonism alone. This has opened new avenues of inquiry into receptor cross-talk, intracellular signaling convergence, and the broader implications of multi-target incretin therapeutics within a laboratory setting.

Laboratory studies involving Tirzepatide have examined its receptor binding kinetics at both the GIP and GLP-1 receptor sites, exploring binding affinity, receptor occupancy duration, and the resulting downstream cyclic AMP (cAMP) signaling pathways. These studies contribute to a growing body of research literature investigating how dual-incretin agonism may differ mechanistically from traditional single-target approaches, offering researchers new frameworks for understanding metabolic peptide pharmacology.

In addition to receptor-level research, Tirzepatide has been studied within various preclinical models examining broader metabolic pathway modulation. This includes research into how dual-incretin receptor activation may influence cellular signaling networks associated with energy homeostasis, nutrient sensing pathways, and related metabolic processes at the molecular level. Such research has contributed valuable insight into the pharmacodynamic profile of multi-receptor agonist compounds more broadly, extending beyond Tirzepatide alone into the wider field of incretin-based peptide research.

Our Tirzepatide is available in multiple concentrations — 10mg, 30mg, 60mg, and 80mg — to accommodate a wide range of research protocols and experimental designs. Each vial is supplied as a lyophilized powder, ensuring long-term stability when stored appropriately. Lyophilization is the preferred method for peptide preservation in research settings because it significantly extends shelf life compared to liquid formulations, protecting the integrity of the peptide structure until the researcher is ready for reconstitution.

Quality and verification are central to how we source and distribute every compound in our catalog, and Tirzepatide is no exception. Each batch is independently third-party tested to verify both identity and purity, ensuring that researchers receive a product that has been rigorously evaluated using industry-standard analytical methods, including High-Performance Liquid Chromatography (HPLC). Certificates of Analysis (COAs) documenting these results are made available on our Lab Reports page or upon request, allowing researchers to review batch-specific testing data prior to use in their studies.

Proper storage is essential to maintaining the integrity of any lyophilized peptide compound. Prior to reconstitution, Tirzepatide should be stored at 0°F or below to preserve long-term stability. Once reconstituted with an appropriate diluent such as bacteriostatic water, the solution should be stored under refrigeration at approximately 36-46°F and used within the timeframe appropriate for reconstituted peptide solutions. Proper handling, including protection from light and minimizing freeze-thaw cycles, further supports the compound’s stability throughout the research period.

As with all products offered by Peptide Pantry, Tirzepatide is intended strictly for laboratory research and in-vitro study purposes. It is not intended for human or animal consumption, and all customers must be 18 years of age or older to purchase. We remain committed to transparency, quality control, and independent verification across our entire product catalog, and Tirzepatide reflects that same standard of rigor and accountability that researchers have come to expect from Peptide Pantry.

All products sold by Peptide Pantry are intended strictly for laboratory research and scientific study purposes only. Not intended for human or animal consumption. Must be 18 or older to purchase.